Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ji-Won Kim"'
Publikováno v:
Journal of Gastroenterology and Hepatology. 34:544-551
Background and aim Inflammatory bowel diseases is associated with an increased risk for the development of colorectal cancer. However, the mechanism of immune signaling pathways linked to colitis-associated cancer (CAC) has not been fully elucidated.
Autor:
Jong Pil Im, Hyun Chae Jung, Ji Won Kim, Byeong Gwan Kim, Joo Sung Kim, Seong-Joon Koh, Yoo Min Han, Kook Lae Lee
Publikováno v:
Journal of Gastroenterology and Hepatology. 31:1436-1442
Background and Aim The presence of perianal disease in Crohn's disease patients is one of the factors of postoperative recurrence. The aim of this study is to evaluate long-term prognosis of perianal Crohn's disease patients in Asian. Methods Patient
Autor:
Sohee Oh, Won Kim, Kook Lae Lee, Ji Won Kim, Su Hwan Kim, Yong Jin Jung, Hwi Young Kim, Ji Bong Jeong, Byeong Gwan Kim
Publikováno v:
Journal of Gastroenterology and Hepatology. 31:814-821
BACKGROUND AND AIM Gastrointestinal bleeding (GIB) often accompanies alcoholic hepatitis (AH). The study aimed to investigate clinical characteristics of GIB in AH patients and to identify risk factors for mortality in AH patients with GIB. METHODS D
Autor:
Hyoun Woo Kang, Young-Ho Kim, Dong Il Park, Yoon Suk Jung, Jae Hee Cheon, Ji Won Kim, Pyoung Ju Seo, Ji Hyun Lee
Publikováno v:
Journal of Gastroenterology and Hepatology. 30:1705-1712
Background and Aim The biosimilar of infliximab, CT-P13, has recently been shown to be equivalent to infliximab in both efficacy and safety in the treatment of rheumatologic diseases. However, no data are available with respect to the drug's efficacy
Autor:
Jung Hwan Yoon, Joo Sung Kim, Kook Lae Lee, Byeong Gwan Kim, Hyun Chae Jung, Seong-Joon Koh, Hyo-Suk Lee, Yong Jin Jung, Yoon Jun Kim, Jong Pil Im, Ji Won Kim, Won Kim, Jee Hye Kwon
Publikováno v:
Journal of Gastroenterology and Hepatology. 29:775-781
Background and Aim The aims of this study were to investigate whether acid suppressive therapy increases the risk of spontaneous bacterial peritonitis (SBP) and to define factors associated with mortality in cirrhotic patients with SBP. Methods Cirrh
Autor:
Suck-Ho Lee, Ja-Seol Koo, Eun Soo Kim, Chang Kyun Lee, Young Sook Park, Jong Pil Im, Yoon Tae Jeen, Dong Il Park, Hyo Jong Kim, Kang-Moon Lee, Ju Yeon Cho, Tae Oh Kim, Ji Won Kim, Chang Hwan Choi, You Sun Kim, Soo Jung Park, Byung Ik Jang
Publikováno v:
Journal of Gastroenterology and Hepatology. 28:1829-1833
Background/Aims Infliximab is currently used for the treatment of moderate-to-severe ulcerative colitis (UC) with an inadequate response to conventional agents. The efficacy and safety of infliximab in Korean patients with UC were assessed. Methods T